Yu et al., 2024 identified PRGs in calcific aortic valve disease where as putative pharmacological targets for the treatment of calcified valve diseases.These potential targets in cardiovascular diseases highlight the significance of pyroptosis in the development of HF and identify novel opportunities for pharmacological interventions and targeting. This evidence concerns the gene GART and cardiovascular disorder.